(PHM) PulteGroup - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7458671010
Stock: Housing, Land, Mortgages, Title, Insurance
Total Rating 38
Risk 56
Buy Signal -1.05
| Risk 5d forecast | |
|---|---|
| Volatility | 33.4% |
| Relative Tail Risk | -9.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | -2.95 |
| Character TTM | |
|---|---|
| Beta | 1.012 |
| Beta Downside | 1.235 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.01% |
| CAGR/Max DD | 0.86 |
EPS (Earnings per Share)
Revenue
Description: PHM PulteGroup March 04, 2026
PulteGroup, Inc. (PHM) operates in the homebuilding sector in the United States. Its core business involves acquiring and developing land, then constructing and selling various residential properties, including single-family homes, townhomes, condominiums, and duplexes.
The company utilizes multiple brands, such as Centex, Pulte Homes, and Del Webb, to target different market segments. Homebuilders often differentiate their offerings through brand recognition and community design. PulteGroup also extends its services to include mortgage banking, title, and insurance operations, a common strategy in the housing industry to provide comprehensive customer solutions and capture additional revenue streams.
For more detailed financial analysis of PHM and its peers, consider exploring ValueRay.
Headlines to watch out for
- Mortgage rate fluctuations impact homebuyer affordability
- Land acquisition costs influence profit margins
- Housing demand shifts affect sales volume
- Regulatory changes in zoning and building codes pose risks
- Economic growth drives consumer confidence in housing
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.22b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.69 > 1.0 |
| NWC/Revenue: 72.94% < 20% (prev 73.29%; Δ -0.35% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.87b > Net Income 2.22b |
| Net Debt (394.4m) to EBITDA (3.02b): 0.13 < 3 |
| Current Ratio: 5.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (195.8m) vs 12m ago -5.04% < -2% |
| Gross Margin: 26.75% > 18% (prev 0.29%; Δ 2646 % > 0.5%) |
| Asset Turnover: 97.77% > 50% (prev 103.4%; Δ -5.58% > 0%) |
| Interest Coverage Ratio: 4813 > 6 (EBITDA TTM 3.02b / Interest Expense TTM 605.0k) |
Altman Z'' 9.38
| A: 0.70 (Total Current Assets 15.20b - Total Current Liabilities 2.57b) / Total Assets 18.05b |
| B: 0.53 (Retained Earnings 9.49b / Total Assets 18.05b) |
| C: 0.16 (EBIT TTM 2.91b / Avg Total Assets 17.71b) |
| D: 1.88 (Book Value of Equity 9.50b / Total Liabilities 5.06b) |
| Altman-Z'' Score: 9.38 = AAA |
Beneish M -2.15
| DSRI: 1.09 (Receivables 265.9m/253.4m, Revenue 17.31b/17.95b) |
| GMI: 1.09 (GM 26.75% / 29.09%) |
| AQI: 2.24 (AQ_t 0.14 / AQ_t-1 0.06) |
| SGI: 0.96 (Revenue 17.31b / 17.95b) |
| TATA: 0.02 (NI 2.22b - CFO 1.87b) / TA 18.05b) |
| Beneish M-Score: -2.15 (Cap -4..+1) = BB |
What is the price of PHM shares?
As of March 11, 2026, the stock is trading at USD 124.39 with a total of 2,023,770 shares traded.
Over the past week, the price has changed by -5.79%, over one month by -9.42%, over three months by -2.54% and over the past year by +16.75%.
Over the past week, the price has changed by -5.79%, over one month by -9.42%, over three months by -2.54% and over the past year by +16.75%.
Is PHM a buy, sell or hold?
PulteGroup has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy PHM.
- StrongBuy: 7
- Buy: 3
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PHM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 143.4 | 15.3% |
| Analysts Target Price | 143.4 | 15.3% |
PHM Fundamental Data Overview March 11, 2026
P/E Trailing = 11.1862
P/E Forward = 12.4224
P/S = 1.3819
P/B = 1.8741
P/EG = 1.1289
Revenue TTM = 17.31b USD
EBIT TTM = 2.91b USD
EBITDA TTM = 3.02b USD
Long Term Debt = 1.63b USD (from longTermDebt, last quarter)
Short Term Debt = 560.9m USD (from shortTermDebt, last quarter)
Debt = 2.40b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 394.4m USD (from netDebt column, last quarter)
Enterprise Value = 24.35b USD (23.92b + Debt 2.40b - CCE 1.98b)
Interest Coverage Ratio = 4813 (Ebit TTM 2.91b / Interest Expense TTM 605.0k)
EV/FCF = 13.92x (Enterprise Value 24.35b / FCF TTM 1.75b)
FCF Yield = 7.18% (FCF TTM 1.75b / Enterprise Value 24.35b)
FCF Margin = 10.10% (FCF TTM 1.75b / Revenue TTM 17.31b)
Net Margin = 12.82% (Net Income TTM 2.22b / Revenue TTM 17.31b)
Gross Margin = 26.75% ((Revenue TTM 17.31b - Cost of Revenue TTM 12.68b) / Revenue TTM)
Gross Margin QoQ = 24.78% (prev 27.77%)
Tobins Q-Ratio = 1.35 (Enterprise Value 24.35b / Total Assets 18.05b)
Interest Expense / Debt = 0.01% (Interest Expense 167.0k / Debt 2.40b)
Taxrate = 23.45% (153.6m / 655.2m)
NOPAT = 2.23b (EBIT 2.91b * (1 - 23.45%))
Current Ratio = 5.91 (Total Current Assets 15.20b / Total Current Liabilities 2.57b)
Debt / Equity = 0.19 (Debt 2.40b / totalStockholderEquity, last quarter 12.99b)
Debt / EBITDA = 0.13 (Net Debt 394.4m / EBITDA 3.02b)
Debt / FCF = 0.23 (Net Debt 394.4m / FCF TTM 1.75b)
Total Stockholder Equity = 12.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.53% (Net Income 2.22b / Total Assets 18.05b)
RoE = 17.51% (Net Income TTM 2.22b / Total Stockholder Equity 12.67b)
RoCE = 20.36% (EBIT 2.91b / Capital Employed (Equity 12.67b + L.T.Debt 1.63b))
RoIC = 15.10% (NOPAT 2.23b / Invested Capital 14.76b)
WACC = 8.76% (E(23.92b)/V(26.33b) * Re(9.64%) + D(2.40b)/V(26.33b) * Rd(0.01%) * (1-Tc(0.23)))
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.74%
[DCF] Terminal Value 77.34% ; FCFF base≈1.67b ; Y1≈1.91b ; Y5≈2.63b
[DCF] Fair Price = 202.2 (EV 39.24b - Net Debt 394.4m = Equity 38.85b / Shares 192.1m; r=8.76% [WACC]; 5y FCF grow 16.44% → 2.90% )
EPS Correlation: 36.86 | EPS CAGR: 9.36% | SUE: -0.70 | # QB: 0
Revenue Correlation: 51.22 | Revenue CAGR: 10.70% | SUE: 1.39 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.62 | Chg7d=+0.011 | Chg30d=+0.017 | Revisions Net=-7 | Analysts=13
EPS current Year (2026-12-31): EPS=10.17 | Chg7d=+0.021 | Chg30d=-0.011 | Revisions Net=-11 | Growth EPS=-8.5% | Growth Revenue=-4.7%
EPS next Year (2027-12-31): EPS=11.32 | Chg7d=+0.081 | Chg30d=-0.191 | Revisions Net=-5 | Growth EPS=+11.3% | Growth Revenue=+5.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 9.6% - Earnings Yield 8.9%)
[Growth] Growth Spread = -5.5% (Analyst -4.8% - Implied 0.7%)
P/E Forward = 12.4224
P/S = 1.3819
P/B = 1.8741
P/EG = 1.1289
Revenue TTM = 17.31b USD
EBIT TTM = 2.91b USD
EBITDA TTM = 3.02b USD
Long Term Debt = 1.63b USD (from longTermDebt, last quarter)
Short Term Debt = 560.9m USD (from shortTermDebt, last quarter)
Debt = 2.40b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 394.4m USD (from netDebt column, last quarter)
Enterprise Value = 24.35b USD (23.92b + Debt 2.40b - CCE 1.98b)
Interest Coverage Ratio = 4813 (Ebit TTM 2.91b / Interest Expense TTM 605.0k)
EV/FCF = 13.92x (Enterprise Value 24.35b / FCF TTM 1.75b)
FCF Yield = 7.18% (FCF TTM 1.75b / Enterprise Value 24.35b)
FCF Margin = 10.10% (FCF TTM 1.75b / Revenue TTM 17.31b)
Net Margin = 12.82% (Net Income TTM 2.22b / Revenue TTM 17.31b)
Gross Margin = 26.75% ((Revenue TTM 17.31b - Cost of Revenue TTM 12.68b) / Revenue TTM)
Gross Margin QoQ = 24.78% (prev 27.77%)
Tobins Q-Ratio = 1.35 (Enterprise Value 24.35b / Total Assets 18.05b)
Interest Expense / Debt = 0.01% (Interest Expense 167.0k / Debt 2.40b)
Taxrate = 23.45% (153.6m / 655.2m)
NOPAT = 2.23b (EBIT 2.91b * (1 - 23.45%))
Current Ratio = 5.91 (Total Current Assets 15.20b / Total Current Liabilities 2.57b)
Debt / Equity = 0.19 (Debt 2.40b / totalStockholderEquity, last quarter 12.99b)
Debt / EBITDA = 0.13 (Net Debt 394.4m / EBITDA 3.02b)
Debt / FCF = 0.23 (Net Debt 394.4m / FCF TTM 1.75b)
Total Stockholder Equity = 12.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.53% (Net Income 2.22b / Total Assets 18.05b)
RoE = 17.51% (Net Income TTM 2.22b / Total Stockholder Equity 12.67b)
RoCE = 20.36% (EBIT 2.91b / Capital Employed (Equity 12.67b + L.T.Debt 1.63b))
RoIC = 15.10% (NOPAT 2.23b / Invested Capital 14.76b)
WACC = 8.76% (E(23.92b)/V(26.33b) * Re(9.64%) + D(2.40b)/V(26.33b) * Rd(0.01%) * (1-Tc(0.23)))
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.74%
[DCF] Terminal Value 77.34% ; FCFF base≈1.67b ; Y1≈1.91b ; Y5≈2.63b
[DCF] Fair Price = 202.2 (EV 39.24b - Net Debt 394.4m = Equity 38.85b / Shares 192.1m; r=8.76% [WACC]; 5y FCF grow 16.44% → 2.90% )
EPS Correlation: 36.86 | EPS CAGR: 9.36% | SUE: -0.70 | # QB: 0
Revenue Correlation: 51.22 | Revenue CAGR: 10.70% | SUE: 1.39 | # QB: 1
EPS next Quarter (2026-06-30): EPS=2.62 | Chg7d=+0.011 | Chg30d=+0.017 | Revisions Net=-7 | Analysts=13
EPS current Year (2026-12-31): EPS=10.17 | Chg7d=+0.021 | Chg30d=-0.011 | Revisions Net=-11 | Growth EPS=-8.5% | Growth Revenue=-4.7%
EPS next Year (2027-12-31): EPS=11.32 | Chg7d=+0.081 | Chg30d=-0.191 | Revisions Net=-5 | Growth EPS=+11.3% | Growth Revenue=+5.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.7% (Discount Rate 9.6% - Earnings Yield 8.9%)
[Growth] Growth Spread = -5.5% (Analyst -4.8% - Implied 0.7%)